-
Bristol-Myers Squibb Company (BMY $44.92)
-
Eli Lilly and Company (LLY $742.36)
-
Novo Nordisk A/S (NVO $45.32)
Q: BMY:
1 What is your current assessment of BMY?
2. Its share price has dropped in the last year. Does it have reasonable prospects to increase from here?
3. It has a somewhat attractive dividend, around 4.75%. Is that sustainable? Does it have any history of dividend increases?
4. Can you describe its pipeline potential?
Many thanks for your excellent service.
1 What is your current assessment of BMY?
2. Its share price has dropped in the last year. Does it have reasonable prospects to increase from here?
3. It has a somewhat attractive dividend, around 4.75%. Is that sustainable? Does it have any history of dividend increases?
4. Can you describe its pipeline potential?
Many thanks for your excellent service.